This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding Corp. with financial support from Tonix. The two organizations ...

The deepening market sell off has not spared many of the big commercialised, profitable biotechs. But the question is whether ...

Time is a scarce resource at the doctor’s office, with the average visit lasting nearly 19 minutes, according to 2023 ...

Lawmakers passed a heap of bills by a key legislative deadline last Thursday, signing off on an accelerated income tax rate cut and a one-time rebate of $250–$500. But by the end of the day, many high ...

Until the pandemic, I had never heard the term. Now it seems like everyone has it, whether they have long COVID or not.

As Kris Aquino battles her multiplying autoimmune diseases, she also has to bear with another broken heart. Six months after ...

Congress passed the Full-Year Continuing Appropriations and Extensions Act funding the government for the remainder of Fiscal Year 2025—through September 30, 2025-- at current funding levels, with a ...

The Food and Drug Administration (FDA) has accepted the supplemental Biologics License Application (sBLA) for obinutuzumab (Gazyva®) for the treatment of lupus nephritis.

Lupus is an autoimmune disease where the body’s immune system attacks its own tissues and organs, causing inflammation and ...

The stars of 'The White Lotus' test who knows one another best in this episode of Vanity Fair Game Show. They filmed together ...